Precision Medicine Researchers Identify New Alzheimer’s Genes
Researchers from Boston University School of Medicine, in
collaboration with scientists from the Alzheimer’s Disease Sequencing Project
(ADSP), have discovered new genes that could contribute to the onset of
Alzheimer’s disease. The new discovery may advance precision medicine
treatments for the degenerative condition.
The National Institutes of Health developed ADSP in response
to the National Alzheimer’s Project Act, which aims to improve health outcomes
and reduce financial burdens for individuals with Alzheimer’s.
Alzheimer’s is the leading cause of dementia and the sixth
leading cause of death in the US. However, despite the growing prevalence and
rising costs of the condition, the genetic and environmental factors that make
some individuals more susceptible to this disease are still not well
understood.
“This is a critical time in Alzheimer's research, with new
opportunities to build upon what we have learned,” Richard J. Hodes, MD,
Director of the National Institute on Aging, said at the time.
Comments
Post a Comment